1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Middle East & Africa ECMO Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Middle East & Africa ECMO Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. Middle East & Africa ECMO Market Regional Analysis
6.1 Middle East & Africa ECMO Market Overview
6.2 Middle East & Africa ECMO Market Revenue 2020-2028 (US$ Million)
6.3 Middle East & Africa ECMO Market Forecast Analysis
7. Middle East & Africa ECMO Market Analysis – by Modality
7.1 Venoarterial ECMO
- 7.1.1 Overview
- 7.1.2 Venoarterial ECMO: Middle East & Africa ECMO Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Venovenous ECMO
- 7.2.1 Overview
- 7.2.2 Venovenous ECMO: Middle East & Africa ECMO Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Arteriovenous ECMO
- 7.3.1 Overview
- 7.3.2 Arteriovenous ECMO: Middle East & Africa ECMO Market – Revenue and Forecast to 2031 (US$ Million)
8. Middle East & Africa ECMO Market Analysis – by Application
8.1 Respiratory
- 8.1.1 Overview
- 8.1.2 Respiratory: Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)
8.2 Cardiology
- 8.2.1 Overview
- 8.2.2 Cardiology: Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9. Middle East & Africa ECMO Market Analysis – by Age Group
9.1 Adults
- 9.1.1 Overview
- 9.1.2 Cardiology: Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9.2 Pediatrics
- 9.2.1 Overview
- 9.2.2 Cardiology: Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)
9.3 Neonates
- 9.3.1 Overview
- 9.3.2 Cardiology: Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)
10. Middle East & Africa ECMO Market – Middle East and Africa Analysis
10.1 Middle East and Africa
- 10.1.1 Middle East & Africa ECMO Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.1.1.1 Middle East & Africa ECMO Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 South Africa:
Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.1.1 South Africa: Middle East & Africa ECMO Market Breakdown, by Modality
- 10.1.1.1.2 South Africa: Middle East & Africa ECMO Market Breakdown, by Application
- 10.1.1.1.3 South Africa: Middle East & Africa ECMO Market Breakdown, by Age Group
- 10.1.1.2 Saudi Arabia:
Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.2.1 Saudi Arabia: Middle East & Africa ECMO Market Breakdown, by Modality
- 10.1.1.2.2 Saudi Arabia: Middle East & Africa ECMO Market Breakdown, by Application
- 10.1.1.2.3 Saudi Arabia: Middle East & Africa ECMO Market Breakdown, by Age Group
- 10.1.1.3 UAE:
Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.3.1 UAE: Middle East & Africa ECMO Market Breakdown, by Modality
- 10.1.1.3.2 UAE: Middle East & Africa ECMO Market Breakdown, by Application
- 10.1.1.3.3 UAE: Middle East & Africa ECMO Market Breakdown, by Age Group
- 10.1.1.4 Rest of Middle East and Africa:
Middle East & Africa ECMO Market – Revenue and Forecast to 2028 (US$ Million)
- 10.1.1.4.1 Rest of Middle East and Africa: Middle East & Africa ECMO Market Breakdown, by Modality
- 10.1.1.4.2 Rest of Middle East and Africa: Middle East & Africa ECMO Market Breakdown, by Application
- 10.1.1.4.3 Rest of Middle East and Africa: Middle East & Africa ECMO Market Breakdown, by Age Group
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Middle East & Africa ECMO Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 ABIOMED Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Braile Biomedica
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Fresenius Medical Care AG & Co KGaA
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Getinge AB
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 LivaNova Plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Medtronic Plc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 MicroPort Scientific Corporation
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Nipro Medical Corporation
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Terumo Group
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights